Dudediligence.

Evommune, Inc

EVMNNYSE · Pharmaceutical Preparations
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Oct 18-KRegulation FD disclosure7.019.01
  2. Sep 238-KRegulation FD disclosure7.019.01
  3. Sep 158-KRegulation FD disclosure7.019.01
  4. Sep 8424B3Prospectus for an offering
  5. Sep 88-KRegulation FD disclosure and other events7.018.019.01
  6. Aug 1413GPassive stake of 5% or more (13G), filed by Price T Rowe Associates Inc /md/
  7. Aug 6424B3Prospectus for an offering
  8. Aug 610-QQuarterly report
  9. Aug 68-KResults of operations2.029.01
  10. Jul 308-KRegulation FD disclosure7.019.01
  11. Jul 1613GPassive stake of 5% or more (13G), filed by Point72 Asset Management
  12. Jun 29424B3Prospectus for an offering
  13. Jun 298-KRegulation FD disclosure and other events7.018.019.01
  14. Jun 2424B3Prospectus for an offering
  15. Jun 28-KShareholder vote5.07
  16. May 7424B3Prospectus for an offering
  17. May 710-QQuarterly report
  18. May 78-KResults of operations and Regulation FD disclosure2.027.01
  19. Apr 24424B3Prospectus for an offering
  20. Apr 17S-1Registration of new shares
  21. Apr 138-KRegulation FD disclosure7.019.01
  22. Mar 510-KAnnual report
  23. Mar 58-KResults of operations2.02
  24. Feb 138-KMaterial agreement and unregistered sale of shares1.013.027.019.01
  25. Feb 108-KRegulation FD disclosure7.019.01
  26. Dec 11, 202510-QQuarterly report
  27. Dec 11, 20258-KResults of operations2.029.01
  28. Nov 7, 20258-KBylaws or fiscal year changed5.039.01
  29. Nov 6, 2025424B4Prospectus for an offering
  30. Oct 9, 2025S-1Registration of new shares